CFG
LMNL

Citizens Financial Group’s Liminal BioSciences Inc. Common Shares LMNL Stock Holding History

Citizens Financial Group’s Portfolio LMNL Stock Details LMNL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2
Closed – – 1007
2020
Q2 		$0 Buy
+2
New +$177 ﹤0.01% 1223

Other funds holding LMNL

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
AI
Atom Investors Austin, Texas $1.4B AUM 23.77% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Citizens Financial Group's LMNL Position: Q3 2020 in Review

Citizens Financial Group sold out of Liminal BioSciences Inc. Common Shares (LMNL) in Q3 2020, closing a stake of 2 shares.

Citizens Financial Group first reported a position in LMNL in Q2 2020 and held it in 1 quarter. The position peaked at $0 in Q2 2020. 14 funds tracked by Wall St. Rank hold LMNL as of Q3 2020.

  • Citizens Financial Group reported no remaining Liminal BioSciences Inc. Common Shares position as of Q3 2020 after selling out during the quarter.
  • Citizens Financial Group sold 2 Liminal BioSciences Inc. Common Shares shares in Q3 2020.
  • Citizens Financial Group first reported a position in Liminal BioSciences Inc. Common Shares in Q2 2020 and held it in 1 quarter.
  • Citizens Financial Group's Liminal BioSciences Inc. Common Shares position peaked at $0 in Q2 2020.
  • 14 funds tracked by Wall St. Rank held Liminal BioSciences Inc. Common Shares as of Q3 2020.

Based on Citizens Financial Group's 13F filing for Q3 2020, filed 12 Nov 2020.